These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25701649)

  • 21. Immunization of mice with Plasmodium TCTP delays establishment of Plasmodium infection.
    Taylor KJ; Van TT; MacDonald SM; Meshnick SR; Fernley RT; Macreadie IG; Smooker PM
    Parasite Immunol; 2015 Jan; 37(1):23-31. PubMed ID: 25376500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against malaria is conferred by passive transferring rabbit F(ab)(2)' antibody fragments, induced by Plasmodium falciparum MSP-1 site-directed designed pseudopeptide-BSA conjugates assessed in a rodent model.
    Lozano JM; Lesmes LP; Gallego GM; Patarroyo ME
    Mol Immunol; 2011 Jan; 48(4):657-69. PubMed ID: 21131051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.
    Calvo PA; Daly TM; Long CA
    Exp Parasitol; 1996 Jan; 82(1):54-64. PubMed ID: 8617331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmodium berghei bio-burden correlates with parasite lactate dehydrogenase: application to murine Plasmodium diagnostics.
    De SL; Stanisic DI; Rivera F; Batzloff MR; Engwerda C; Good MF
    Malar J; 2016 Jan; 15():3. PubMed ID: 26729268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
    Aly AS; Downie MJ; Mamoun CB; Kappe SH
    Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations.
    Kats LM; Wang L; Murhandarwati EE; Mitri K; Black CG; Coppel RL
    Vaccine; 2008 Jun; 26(26):3261-7. PubMed ID: 18468741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).
    Ahlborg N; Ling IT; Holder AA; Riley EM
    Infect Immun; 2000 Apr; 68(4):2102-9. PubMed ID: 10722607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
    Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
    Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL; Daly TM; Clynes R; Long CA
    J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and protective potential of a Plasmodium spp. enolase peptide displayed on archaeal gas vesicle nanoparticles.
    Dutta S; DasSarma P; DasSarma S; Jarori GK
    Malar J; 2015 Oct; 14():406. PubMed ID: 26463341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
    Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
    Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of antibody-dependent respiratory burst activity from mouse neutrophils on Plasmodium yoelii malaria challenge outcome.
    Llewellyn D; de Cassan SC; Williams AR; Douglas AD; Forbes EK; Adame-Gallegos JR; Shi J; Pleass RJ; Draper SJ
    J Leukoc Biol; 2014 Feb; 95(2):369-82. PubMed ID: 24163420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria.
    Mello K; Daly TM; Long CA; Burns JM; Bergman LW
    Infect Immun; 2004 Feb; 72(2):1010-8. PubMed ID: 14742548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An essential role for C5aR signaling in the optimal induction of a malaria-specific CD4+ T cell response by a whole-killed blood-stage vaccine.
    Liu T; Xu G; Guo B; Fu Y; Qiu Y; Ding Y; Zheng H; Fu X; Wu Y; Xu W
    J Immunol; 2013 Jul; 191(1):178-86. PubMed ID: 23709683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.
    Daly TM; Long CA
    J Immunol; 1995 Jul; 155(1):236-43. PubMed ID: 7602100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of invasive Plasmodium yoelii merozoites with a long half-life to evaluate invasion dynamics and potential invasion inhibitors.
    Mutungi JK; Yahata K; Sakaguchi M; Kaneko O
    Mol Biochem Parasitol; 2015 Nov; 204(1):26-33. PubMed ID: 26684675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys.
    Dutta S; Kaushal DC; Ware LA; Puri SK; Kaushal NA; Narula A; Upadhyaya DS; Lanar DE
    Infect Immun; 2005 Sep; 73(9):5936-44. PubMed ID: 16113314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.